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Cellular/Molecular
Phosphatidylinositol 3 Kinase Activation and AMPA
Receptor Subunit Trafficking Underlie the Potentiation of
Miniature EPSC Amplitudes Triggered by the Activation of
L-Type Calcium Channels
AndrewW. Baxter and David J. A. Wyllie
Division of Neuroscience, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom
Wehave characterized amechanismbywhich the amplitudes ofminiature EPSCs (mEPSCs) in CA1 pyramidal neurons in rat hippocam-
pal organotypic slice cultures are potentiated by approximately twofold after a series of depolarizing voltage pulses from–80 to20mV.
The increase in mEPSC amplitudes is triggered by the activation of L-type calcium channels and is independent of NMDA receptor
(NMDAR)activationbut also requires calciumrelease from intracellular stores. Thepotentiation inducedbydepolarizingpulsesdoesnot
alter the kinetic parameters of mEPSCs. The induction phase of this potentiation involves phosphatidylinositol 3 kinase (PI3 kinase)
activation because it is blocked completely in the presence of the PI3 kinase inhibitors wortmannin and 2-(4-morpholinyl)-8-phenyl-4H-
1-benzopyran-4-one (LY294002). Furthermore, we show that themaintenance phase of depolarizing pulse potentiation requires contin-
ued PI3 kinase activity because the application of either wortmannin or LY294002 results in a reversal to control levels of the amplitudes
ofmEPSCs. Finally, we demonstrate that the increase inmEPSC amplitudes ismediated by the increased expression of functional AMPA
receptors (AMPARs) because the potentiation is blocked by N-ethylmaleimide, botulinum toxin A, and a variety of short-sequence
peptides that disrupt the interaction of AMPAR subunits with proteins involved with the trafficking of these to the cell membrane. Our
data are consistent with the notion that PI3 kinase andmembrane fusion/trafficking events play a pivotal role in coordinating changes in
synaptic strength,mediatedbyAMPAreceptors,which are triggeredby alterations inpostsynaptic calciumconcentrationswhether these
changes are initiated via NMDAR-dependent or NMDAR-independent routes.
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Introduction
The best studied cellular model of synaptic plasticity, NMDA
receptor-dependent (NMDAR-dependent) long-term potentia-
tion (LTP), contains many of the elements required of activity-
dependent changes in synaptic strength that are thought to un-
derlie learning and memory in the mammalian CNS. A
fundamental observation concerning the induction of this form
of LTP is its absolute requirement for a rise in the intracellular
calcium level, triggered by calcium entry via the NMDAR. Typi-
cally, this form of plasticity is monitored by recording the ampli-
tude of evoked AMPA receptor-mediated (AMPAR-mediated)
synaptic currents (or potentials). It is, however, also possible to
record the spontaneous activity in a neuron. Suchminiature syn-
aptic events result from the activation of AMPARs after the spon-
taneous, tetrodotoxin-insensitive, release of single vesicles of glu-
tamate from the presynaptic nerve terminal and can provide
insights into the mechanisms by which changes in synaptic
strength occur. CA1 pyramidal neurons, however, contain many
thousands of synaptic sites, and typical LTP-inducing protocols
result in only a small proportion of synaptic sites experiencing
activity-related changes in synaptic strength, making it difficult
to resolve changes in miniature synaptic events. Previously, we
have described amethod for studying changes inminiature EPSC
(mEPSC) amplitudes in CA1 pyramidal neurons that are trig-
gered by rises in postsynaptic calcium after the activation of
L-type calcium channels (Wyllie and Nicoll, 1994; Wyllie et al.,
1994). This depolarizing pulse-induced potentiation (DPP),
which is distinct from conventional NMDAR-mediated LTP,
gives rise to a twofold potentiation of mEPSC amplitudes and
causes large changes in intracellular calcium levels that most
likely allows for potentiation at many more synapses than can
occur with either pairing-induced or tetanus-induced LTP (Per-
kel et al., 1993).
In this studywe have usedDPPofmEPSC amplitudes to assess
the contribution of two signaling pathways implicated in
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NMDAR-dependent LTP to determine whether these also are
activated when changes in intracellular calcium levels are medi-
ated via NMDAR-independent processes. The first of these is
phosphatidylinositol 3 kinase (PI3 kinase), a kinase that is crucial
for NMDAR-dependent activation of mitogen-activated protein
kinase/extracellular signal-related kinase (MAPK/ERK) (Chan-
dler et al., 2001; Perkinton et al., 2002), and that if inhibited
blocks the induction of LTP (Kelly and Lynch, 2000; Opazo et al.,
2003) and in certain cases regulates the expression of LTP (Sanna
et al., 2002). The second of these is the role of membrane fusion
events as a mechanism to account for the increased amplitude
of mEPSCs that accompanies DPP. The role of soluble
N-ethylmaleimide-sensitive fusion protein attachment protein
receptors (SNAREs) in NMDAR-dependent LTP was demon-
strated by Lledo et al. (1998); subsequently, the idea that
AMPARs are trafficked into and out of synaptic sites as a mech-
anism of regulating synaptic plasticity has gained considerable
support (for review, see Malinow and Malenka, 2002; Bredt and
Nicoll, 2003; Collingridge et al., 2004). The datawe present in this
study show that both PI3 kinase and receptor trafficking/mem-
brane fusion events play pivotal roles in the NMDAR-
independent potentiation of miniature synaptic currents and
suggest that commonmechanisms are responsible for translating
changes in intracellular calcium levels to alterations in synaptic
efficacy.
Materials andMethods
Preparation of organotypic slice cultures. Organotypic hippocampal slice
cultures were prepared from postnatal day 7–10 (P7–P10) male Wistar
rat pups, using themethoddescribed by Stoppini et al. (1991). Briefly, the
animals were decapitated (according to procedures authorized by cur-
rent United Kingdom Home Office regulations); their brains were re-
moved quickly and placed in an ice-cold solution composed of the fol-
lowing (in mM): 125 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 4
MgCl2, 1 CaCl2, and 25 glucose, bubbled with 95% O2/5% CO2. Brains
were hemisected, and each hippocampus removed, glued on to an agar
block, and mounted in a custom-made tissue chamber on a Vibratome
1000 Plus tissue slicer (Campden Instruments, Loughborough, UK). In-
dividual slices (250 m thick) were transferred to 0.4 m Millipore
(Bedford, MA) cell culture membrane inserts placed in 35 mm Petri
dishes containing 1 ml of a cell culture solution that comprised 50%
Eagle’sminimumessentialmedia with Earle’s salts, 25%heat-inactivated
horse serum, 25%Hank’s balanced salts, 50Uof penicillin/streptomycin,
and 2 mM L-glutamine (all from Invitrogen, Paisley, UK). Slices were
placed in a humidified 95% air/5% CO2 incubator at 37°C. The cell
culture medium was replaced three times per week, and electrophysio-
logical recordings were made from 7 to 14 d after the preparation of the
slices. The ability to obtainDPP (or itsmagnitude)was not dependent on
the duration of the culture period.
Electrophysiological recording and analysis of mEPSCs. For the record-
ing of mEPSCs the individual organotypic slices were transferred to a
recording chamber, and CA1 pyramidal neurons were visualized with
Nomarski optics (Zeiss Axioskop FS2, Oberkochen, Germany). The re-
cording chamber (volume, 1.5 ml) was perfused at a rate of 4 ml/min,
with an external recording solution that contained the following (inmM):
119 NaCl, 26 NaHCO3, 2.5 KCl, 1 NaH2PO4, 1.3 MgCl2, 4 CaCl2, and 25
glucose, bubbledwith 95%O2/5%CO2 (300–310mOsm). The following
drugs were used: tetrodotoxin (TTX), picrotoxin, CNQX, D-2-amino-5-
phosphonpentanoic acid (D-AP5) (Tocris Bioscience, Bristol, UK), bot-
ulinum toxin A, nifedipine, N-ethylmaleimide (NEM), BAPTA, thapsi-
gargin, ryanodine, wortmannin, 2-(4-morpholinyl)-8-phenyl- 4H-1-
benzopyran-4-one (LY294002), and 2-(4-piperazinyl)-8-phenyl- 4H-1-
benzopyran-4-one (LY303511) (Sigma–Aldrich, Poole, UK). In addition
to these drugs we used the following small peptides that disrupt the
interaction of AMPAR subunits with SNARE complexes and other pro-
teins involved in the trafficking of these receptors and that are located in
CA1 pyramidal neurons: pep2m, pep4c, pep2-Ala/Val/Lys/Ile (pep2-
AVKI), and pep1-Thr/Gly/Leu (pep1-TGL) (Tocris Bioscience). To re-
strict the action of these peptides to the postsynaptic cell, we included
these in the internal recording solution used to fill the patch pipette. All
recordings of mEPSCs were performed at room temperature (21 2°C)
and were made with the external recording solution supplemented with
TTX (300 nM) to block the action potential-dependent release of synaptic
vesicles and with picrotoxin (50M) to block GABAA receptor-mediated
IPSCs.
Patch pipettes were made from thick-walled borosilicate glass (Har-
vard Apparatus, Kent, UK) and filled with an internal Cs-based
ATP-regenerating solution that contained the following (in mM): 105
Cs-gluconate, 17.5 CsCl, 8 NaCl, 10 HEPES, 0.2 EGTA, 2 Mg-ATP, 2
Na2-ATP, 0.3 Na3-GTP, and 20 phosphocreatine plus 50 U/ml creatine
phosphokinase, pH 7.3, with CsOH (280–290 mOsm). These electrodes
were coated with Sylgard 184 resin (Dow Corning, Midland, MI) to
reduce their capacitance, and their tips were fire-polished. The final re-
sistances of the recording electrodes were between 5 and 10 M.
Whole-cell currents were recorded with an Axopatch-1D amplifier
(Molecular Devices, Union City, CA) and displayed on an oscilloscope;
currents also were stored on digital audio tape for subsequent off-line
analysis. Cells were voltage-clamped at a potential of –80 mV, and, to be
included for analysis, the holding currents had to be less than –150 pA;
series resistances, which typically were 20–30 M, could not drift by
15% during the course of the experiment.
Before the application of depolarizing pulses the amplitudes of mEP-
SCs were measured during a 5 min baseline (control) period. DPP was
induced by applying a series of 10 voltage steps from –80 to 20 mV,
lasting 3 s, given at an interpulse interval of 6 s. In experiments in which
the effects of drugs that inhibited DPP were investigated, we performed
“interleaved” control experiments to ensure that we still were able to
obtain potentiation in cells from sister cultures not treated with the
drugs. In such experiments the recordings were made from treated and
nontreated preparations in an alternate manner. Additionally, for these
interleaved control experiments the external recording solution, and
where appropriate the internal recording solution, contained dimethyl-
sulfoxide or ethanol if these solvents had been used in a particular
experiment.
For the analysis of mEPSCs the currents were replayed from tape,
filtered at 2 kHz, and digitized at 10 kHz by usingWinEDR v6.1 software
(John Dempster, University of Strathclyde, UK; http://spider.science.
strath.ac.uk/PhysPharm/showPage.php?pageName  software). The
amplitudes, frequencies, and kinetic parameters of mEPSCs were mea-
sured with the computer program MiniAnalysis (Synaptosoft, Fort Lee,
NJ). The threshold for the detection of mEPSCs was typically4–6 pA.
To be included for analysis, mEPSCs had to have a monotonic rising
phase with a 10–90 rise time of 6 ms and decays that followed an
exponential time course with a decay time constant of25 ms. The vast
majority of mEPSCs, however, had rise times and decay time constants
considerably less than these upper limits (see below). Amplitude
mEPSCs were measured by subtracting the mean current amplitude re-
corded in the 5ms before the event from the average of five data points at
the peak of the event. Throughout the text we report the absolute ampli-
tudes of mEPSCs, but because these events were recorded as inward
currents, their true amplitude is the negative of the values stated, as is
indicated in the histograms of mEPSC amplitudes. The decay phases of
mEPSCs were fit with single exponential components to obtain an esti-
mate of the decay time constant (decay). Mean mEPSC waveforms were
obtained by averaging between 50 and 100 individual events. Because of
the variation in the mean amplitudes and frequencies of mEPSCs, when
reporting the mean values for data pooled from a series of experiments,
we have normalized these values to those recorded in baseline recording
period before the application of depolarizing pulses. To assess differences
in the distributions of mEPSC amplitudes, we constructed cumulative
probability plots. In such plots we report the median amplitude value
(AV50) of the distribution to allow for comparison between control
mEPSCs distributions and distributions obtained after the application of
depolarizing pulses.
Statistical analysis. All results are given as the mean SEM. Statistical
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analysis of amplitudes (and frequencies) of
mEPSCs recorded in the baseline (control) pe-
riodwith those recorded after the application of
depolarizing pulses was performed with Sig-
maStat v3, using either Mann–Whitney U or
Kolmogorov–Smirnov tests, as appropriate,
with statistical significance taken to be at the
p 0.05 level.
Results
In a series of preliminary experiments we
observed that the frequency of mEPSCs in
acute hippocampal slices prepared from
P7–P14 rat pups was too low ( 0.1Hz) to
permit the recording of a sufficient num-
ber of events, over a typical recording du-
ration of 30–40 min, to allow for their de-
tailed analysis. Recordings from CA1
pyramidal neurons in organotypic slice
culture have indicated that mEPSCs dis-
play higher frequencies but retain similar
kinetic properties when comparedwith re-
cordings made from acute slices (de Si-
moni et al., 2003). Because of these consid-
erations we used the organotypic
hippocampal slice preparation for all of
the experiments described in this work.
Characteristics of mEPSCs recorded
from CA1 pyramidal neurons
In the presence of TTX (300 nM) and pic-
rotoxin (50 M) spontaneous inward cur-
rents with fast monotonic rise times and
exponential decays were readily apparent
in whole-cell current recordings made
from CA1 pyramidal neurons voltage-
clamped at –80 mV (Fig. 1A). These
events were blocked by the application of
CNQX (30 M; n  4 slices) (data not
shown), and we therefore conclude that these events represent
glutamatergic, AMPAR-mediated, TTX-insensitive mEPSCs. No
NMDAR-mediated component to mEPSCs is apparent in these
recordings because they were made in the presence ofMgCl2 (1.3
mM) and at a holding potential at which the voltage-dependent
block of the NMDAR channel by magnesium ions is expected to
be strong. Furthermore, the absence of an NMDAR-mediated
component was confirmed by the lack of sensitivity of both the
amplitude and the decay time constants of mEPSCs to D-AP5 (50
M; n  3 slices) (data not shown). Over a recording period of
30–40 min the distribution of mEPSCs was stable (Fig. 1B), al-
though amplitude histograms of these events showed a skewed
distribution (Fig. 1C) typical of that reported for mEPSCs re-
corded from CA1 pyramidal neurons in both acute and organo-
typic slices (Manabe et al., 1992; Wyllie et al., 1994; de Simoni et
al., 2003). The AV50 value obtained from the cumulative proba-
bility plot in this example is 16.7 pA, whereas the mean mEPSC
amplitude recorded in a series of experiments designed to assess
the stability of amplitudes over prolonged recording periods was
20.6  1.7 pA (n  8) (Fig. 1D, top plot); the range of mean
amplitudes recorded in these experiments was between 15.4 
2.0 and 27.2 2.4 pA. The frequency of mEPSCs during the first
10 min of recording in these experiments was 1.5 0.2 Hz, with
a range of 0.5–2.3 Hz. During the course of recording, however,
we observed that the frequency ofmEPSCs was reduced such that
after 25–30 min of whole-cell recording the mean mEPSC fre-
quency was 1.2 0.3 Hz (n 8) (Fig. 1D, bottom plot). We also
examined whether there were correlations among the rise times,
decay time constants, and amplitudes of mEPSCs. Figure 1E il-
lustrates a series of such correlation plots for 500 randomly
selected events recorded during the course of an experiment. As
can be seen, we observed no significant correlations among any of
these parameters. The mEPSCs we recorded will have originated
throughout the dendritic tree of a CA1 neuron andwill have been
subjected to dendritic filtering such that the rise times, decay
times, and amplitudes will not be equivalent to the values of these
parameters at their site of origin; however, we did not find evi-
dence that large-amplitude events were associated with fast rise
times and decay time constants or vice versa. In these experi-
ments the mean 10–90% rise time of mEPSCs was 1.2 0.1 ms,
whereas the average decay time constant was 8.8 0.3 ms. These
values are in good agreement with previous reports characteriz-
ing mEPSC properties recorded from organotypic hippocampal
slices cultured for a similar period of time (McKinney et al., 1999;
de Simoni et al., 2003). Our criteria for the inclusion of events for
analysis were not so strict as to include only events that originate
in close proximity to the soma (i.e., events with the fastest rise
times) (Smith et al., 2003), because we wanted to ensure that we
included as many events as possible in our studies and because
Figure 1. Properties of mEPSCs recorded from CA1 pyramidal neurons in hippocampal slice cultures. A, Five superimposed
1500 ms sweeps of recordings of mEPSCs recorded from a CA1 pyramidal neuron at a holding potential of – 80 mV. TwomEPSCs
are shown at a 10 times faster time base (indicated by dashed lines).B, Plot of the amplitudes of individualmEPSCs recorded over
a 30min period. C, Amplitude histogram of the data obtained in the first 5min of the recording shown inB. The histogram shows
a clear skew in the distribution. The inset shows the same data as those plotted in the histogram but represented as a cumulative
probability plot. D, Plots showing the mean amplitude of mEPSCs (top graph) and mean mEPSC frequency (bottom graph)
recorded in a series of control experiments (n 8); error bars indicate the mean SEM. There is no apparent rundown in the
amplitude of mEPSCs recorded over a 30 min period. E, Plots showing relationships among the rise times, decay time constants,
and amplitudes of mEPSCs. In no case is there a significant correlation among these parameters.
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the depolarizing pulse stimulation protocol is expected to result
in a cell-wide potentiation of mEPSCs.
Potentiation of mEPSC amplitudes by
postsynaptic depolarization
LTP of glutamatergic synaptic responses in the CA1 region of the
hippocampus is critically dependent on a rise in the postsynaptic
calcium concentration, this rise usually resulting from calcium
entry via theNMDAR (for review, seeNicoll andMalenka, 1999).
It is this initial rise in calcium levels that triggers the biochemical
cascade that ultimately leads to increased synaptic efficacy. Con-
ventional LTP-inducing protocols, however, result only in the
potentiation of comparatively few synapses in a typical CA1 py-
ramidal neuron. This makes it difficult to observe changes in
miniature synaptic currents with these stimulating paradigms,
because after LTP induction the vast majority of events will still
occur at sites that have not experienced any change in synaptic
strength. Previous studies have shown that applying a series of
depolarizing voltage pulses from a holding potential of –80 to
20 mV to hippocampal CA1 pyramidal neurons results in a
robust, although transient, potentiation of both evoked EPSC
and mEPSC amplitudes (Kullmann et al., 1992; Wyllie and
Nicoll, 1994; Wyllie et al., 1994). The transient nature of this
potentiation could be converted to a sustained potentiation in the
presence of protein phosphatase inhibitors (Wyllie and Nicoll,
1994).
In agreement with these earlier studies, we observed that ap-
plying a series of 10 depolarizing pulses from –80 to20 mV to
CA1neurons in organotypic slices cultures resulted in an increase
in the amplitude ofmEPSCs (Fig. 2A). However, as can be seen in
Figure 2, B and C, this protocol resulted in a sustained potentia-
tion of mEPSC amplitudes in contrast to the transient potentia-
tion seen in acute slices. We did not investigate the reasons for
this difference. As shown in Figure 2B and also apparent in the
comparison of amplitude histograms of events recorded before
and after the application of depolarizing pulses (Fig. 2D), there is
a reduction in the number of small-amplitude events and an
increase in the number of large-amplitude events after the poten-
tiation. Figure 2E shows the corresponding cumulative probabil-
ity plot for the data shown in the amplitude histograms. In this
example the AV50 amplitude for mEPSCs recorded in the control
period is 18.2 pA, whereas the corresponding value for mEPSCs
recorded after the application of depolarizing pulses is increased
significantly to 50.7 pA ( p 0.001; Kolmogorov–Smirnov). The
potentiation induced by depolarizing pulses did not alter the rise
times and decay times of mEPSCs (Wyllie et al., 1994). Figure 2F
shows an average of 50 control mEPSCs (gray trace) and 50 po-
tentiated mEPSCs (black trace); when scaled, the control and
potentiated mean mEPSCs are superimposable.
The data from all of the experiments in which depolarizing
pulses were applied in the absence of any pharmacological ma-
nipulations are shown in Figure 3 (n 60). Overall we observed
Figure 2. mEPSC amplitudes are potentiated after a series of depolarizing voltage pulses.A,
Five superimposed sweeps ofmEPSCs recordedbefore (top traces) and after (bottom traces) the
application of depolarizing pulses to a CA1 pyramidal neuron. B, Plot of the individual ampli-
tudes of mEPSCs recorded in an example experiment. Depolarizing pulses were applied after 5
min. It is apparent that after the depolarizing pulses there is an increase in the number of
large-amplitude events (in a given time period) and that there is a shift to larger amplitudes in
the size of the smallest events recorded.C, The samedata as shown inBbut plotted as themean
amplitude ofmEPSCs recorded in 1minbins; error bars indicate themean SEM.D, Amplitude
histogramofdata illustrated inB recorded in the control period (graydashed line/gray symbols)
and in a similar time period at approximately the peak of the potentiation (solid line/black
symbols). There is a clear rightward shift in the plots after the potentiation of mEPSCs. E,
Cumulative probability plot of the data shown in D. F, Examples of mean mEPSC waveforms
obtained by averaging 50 events recorded before the application of depolarizing pulses (gray
trace) and 50 events recorded at approximately the peak of the potentiation (black trace).
Scaling the control mEPSC time course to the same amplitude of the potentiatedmEPSC results
in a superimposition of the two traces and indicates that there is no change in the kinetic
parameters of mEPSCs associated with their increased amplitude.
Figure 3. Mean data from all control experiments performed during the course of this study
(n 60). A, Mean time course of DPP showing that there is an approximately twofold increase
in the amplitude ofmEPSCs triggered by the application of depolarizing pulses, which does not
show a significant decline over the time course of the experiment. B, Plot showing the mean
(normalized) mEPSC frequency; error bars indicate the mean SEM. After the application of
depolarizing pulses there is a small transient potentiation of frequencies. C, Histogram showing
the range in the fold increase ofmEPSC amplitudes after the application of depolarizing pulses.
These values appear to be distributed normally around a mean of a twofold increase. D, No
significant correlation between the mean mEPSC amplitude and the mean frequency is ob-
served. E, F, Plots showing the lack of correlation between either the control mean mEPSC
amplitude or control mean mEPSC frequency and the extent of the potentiation seen after the
application of depolarizing pulses.
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that mEPSC amplitudes increased by ap-
proximately twofold (from 22.1  0.9 to
46.1 0.1 pA) after the application of de-
polarizing pulses (Fig. 3A). No changes
were observed in the overall mean rise
times and decay times of mEPSCs re-
corded before and after the application of
depolarizing pulses, these values being
1.4 0.1 and 11.9 0.1 ms and 1.4 0.1
and 12.6 0.1 ms, respectively. Addition-
ally, and as was the case with the record-
ings illustrated in Figure 1, potentiated
mEPSCs showed no correlations in their
rise times, decay times, and amplitudes
(data not shown). After the potentiation of
mEPSC amplitudes we observed a small
transient but nonsignificant increase in
the frequency of events from 1.6  0.2 to
1.9 0.2Hz ( p 0.05;Mann–WhitneyU
test) (Wyllie et al., 1994). As was the case
with our experiments that monitored
mEPSC parameters in the absence of any
depolarizing pulses (Fig. 1), the frequency
of events decreased with time to70% of
baseline (pre-DPP induction) levels. The
overall mean mEPSC frequency 25–30
min after the induction of DPP was 1.1
0.1 Hz, which is not significantly different
( p  0.05; Mann–Whitney U) from the
value of 1.2  0.3 Hz that we obtained at
25–30 min in the experiments illustrated
in Figure 1D. Because of this generalized
decrease in mEPSC frequency, we have re-
stricted our analysis of the effects of vari-
ous pharmacological manipulations, de-
scribed below, mainly to the potentiation
of mEPSC amplitudes. The distribution of
the extent of potentiation seen across all
experiments was distributed normally
(Fig. 3C). Figure 3D shows that the initial
mean mEPSC amplitude was not depen-
dent on the frequency of events recorded
in a cell, nor did the degree of potentiation inmEPSC amplitudes
show dependence on initial mEPSC amplitude or frequency (Fig.
3E,F). These data could be taken as evidence to indicate either
thatDPPdoes not result in the saturation of spines withAMPARs
(Choquet and Triller, 2003) or that, in addition to increased AM-
PAR expression, DPP results in the modification of AMPAR
function/kinetic behavior such that it has a higher probability of
opening (Erreger et al., 2004). In relation to this latter point it has
been shown recently that Stargazin, a protein involved in the
trafficking of AMPARs, also modulates the kinetic behavior of
these receptors (Tomita et al., 2005).
Sources of calcium required for DPP of mEPSCs
As mentioned above, the main route of calcium entry into the
postsynaptic cell during LTP-stimulating protocols is via the
NMDAR.However, as shown in the examples ofmEPSCs and the
plot of the time course of potentiation illustrated in Figure 4A,
sustained potentiation of mEPSC amplitudes is still observed in
the presence of the NMDAR antagonist D-AP5 (50 M). No dif-
ferences in the magnitude of DPP are observed in experiments
performed in the absence of D-AP5 (Fig. 3A) and those per-
formed under conditions of NMDAR blockade. In another series
of experiments we confirmed that this concentration of D-AP5
was sufficient to block the slow component of a glutamatergic
EPSC recorded at 40 mV (data not shown). Thus, although
depolarizing the neurons to20 mV relieves voltage-dependent
magnesium block, calcium entry via this route is not sufficient to
potentiate mEPSCs.
Although the activation of NMDARs is not required for DPP,
there is an absolute requirement for a rise in postsynaptic calcium
levels for this type of potentiation to occur (Kullmann et al., 1992;
Wyllie et al., 1994). As shown in Figure 4B, the activation of
high-threshold voltage-gated calcium channels is required for
this form of potentiation because nifedipine (10 M; n 3) pre-
vents the depolarizing pulse-induced increase in mEPSC ampli-
tudes. Preventing the rise in calcium levels in the CA1 pyramidal
neuron by including the calcium chelator BAPTA (10mM; n 3)
in the internal recording solution that was used to fill the patch
electrode also resulted in the complete block of potentiation (Fig.
4C). These three observations are in agreement with previously
published data concerning the role of calcium in DPP in acute
hippocampal slices (Wyllie et al., 1994). To assess whether there
Figure 4. DPP is NMDAR independent but requires the activation of L-type calcium channels and calcium release from internal
stores. A, Superimposed sweeps of mEPSC activity recorded before (top traces) and after (bottom traces) the application of
depolarizing pulses in the presence of D-AP5 (50M). There is a clear increase in the amplitude ofmEPSCs in the sweeps shown in
the bottom traces. The time course of the potentiation seen in the presence of D-AP5 (n 5) is not different from that seen in the
absence of this antagonist (the plot below the mEPSC traces). B, Superimposed sweeps of mEPSC activity recorded before (top
traces) and after (bottom traces) the application of depolarizing pulses in the presence of nifedipine (10M). As illustrated in the
plot below themEPSC traces, blocking L-type calcium channels prevents the increase in mEPSC amplitudes, whereas interleaved
control experiments give typical potentiation. C, Preventing the rise in intracellular calcium by including BAPTA (10 mM) in the
recording solution used to fill the patch pipette also prevents potentiation. D, Interfering with intracellular calcium stores by
treating slices with a combination of thapsigargin and ryanodine (each 10M) also blocks potentiation. In this and subsequent
figureswe indicatewhether the pharmacologicalmanipulations used to interferewithDPPwere applied in the external recording
solution (as depicted in A, B, D above the plots) or were included in the internal recording solution (as depicted in C). For
experiments illustrated in A, B, and D, drugs were present throughout the duration of these recordings. Interleaved control
experiments were performed to ensure that reliable DPP could be achieved when experiments examining the pharmacological
characterization of depolarizing pulse potentiation were being undertaken. These are depicted (by filled circles) in B (n 2), C
(n 3), and D (n 4). Error bars indicate the mean SEM.
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was a dependence of DPP on intracellular calcium stores, we
performed a series of experiments in the presence of thapsigargin
and ryanodine (each, 10M; n 6). When used in combination,
these inhibitors deplete intracellular calcium stores and prevent
calcium-induced calcium release, which, as illustrated in Figure
4D, results in a block of DPP. In all cases in which pharmacolog-
ical manipulations that interfered with calcium levels in the cell
resulted in a block of DPP, interleaved control experiments re-
sulted in significant potentiation of mEPSC amplitudes (Fig.
4B–D, filled circles) ( p  0.05; Mann–
Whitney U). Although the most parsimo-
nious explanation for the results described
above is that calcium entry via L-type cal-
cium channels is the initial trigger for DPP
of mEPSCs, our present study and earlier
work (Wyllie et al., 1994) show only that
the activation of these channels is re-
quired. Thus the possibility exists that a
direct protein–protein interaction be-
tween L-type calcium channels and ryano-
dine receptors is responsible for DPP of
mEPSCs. Indeed, direct interactions be-
tween these proteins have been reported
(for review, see Blackstone and Sheng,
1999).
Inhibitors of PI3 kinase block the
induction andmaintenance of voltage
pulse potentiation
PI3 kinase has been implicated as playing a
role in the induction (Kelly and Lynch,
2000; Opazo et al., 2003) andmaintenance
(Sanna et al., 2002) of NMDAR-
dependent LTP in the rat hippocampus.
Additionally, Man and colleagues (2003)
have demonstrated a role for this kinase in
glycine-induced potentiation of mEPSCs
in cultures of hippocampal neurons. We
investigated whether PI3 kinase played a
role in the potentiation of mEPSC ampli-
tudes induced by depolarizing pulses. We
have used two structurally unrelated in-
hibitors to examine the role of PI3 kinase:
wortmannin, an antifungal antibiotic
(Powis et al., 1994), and LY294002, a syn-
thetic and specific inhibitor of PI3 kinase
(Vlahos et al., 1994).
Notwithstanding the role that PI3 ki-
nasemay play in LTP, controversy exists as
to whether PI3 kinase inhibitors, at con-
centrations that affect LTP, also result in
an attenuation of baseline synaptic trans-
mission (Sanna et al., 2002; Opazo et al.,
2003). Figure 5 shows the effects of wort-
mannin (n  4) (Fig. 5A) and LY294002
(n  3) (Fig. 5B) on mEPSC amplitudes
recorded in a series of experiments to
which no depolarizing pulses were ap-
plied. In neither case do these inhibitors, at
the concentrations used in this study, af-
fect the mean amplitude, the shape of the
amplitude histogram, nor the overall dis-
tribution of mEPSCs (as indicated by cu-
mulative probability plots) when compared with recordings
made in the absence of these inhibitors (Fig. 1).
We next examined whether the induction of DPPwas blocked
in the presence of PI3 kinase inhibitors. Figure 5C shows that in
the presence of wortmannin (100 nM) the induction of DPP was
blocked, whereas interleaved control experiments showed typical
potentiation. PI3 kinase has been reported to modulate voltage-
dependent calcium channels (VDCCs) and promote their traf-
ficking to the cell membrane (Steinberg, 2001; Viard et al., 2004);
Figure 5. Inhibitors of PI3 kinase do not affect the amplitudes of mEPSCs recorded under control conditions but do block the
induction of DPP. A, Top, Mean data from experiments (n 4) in which wortmannin (100 nM) was applied to slices, but no
depolarizing pulses were delivered to CA1 neurons. At this concentration, this PI3 kinase inhibitor does not alter themeanmEPSC
amplitude recorded over the time course of the experiment. A, Bottom, Amplitude histogram and cumulative probability plot
(inset) from one of the experiments contributing to the data illustrated at the top recorded either before the application of
wortmannin (gray dashed line/gray symbols) or after the application of this inhibitor (solid line/black symbols). The distribution
of mEPSC amplitudes is not affected by treatment with wortmannin. B, Top, Mean data from experiments (n 3) in which
LY294002 (5M)was applied to slices, but no depolarizing pulseswere delivered to CA1neurons. As is the casewithwortmannin,
this concentration of LY294002 does not alter the mean mEPSC amplitude recorded over the time course of the experiment. B,
Bottom, Amplitude histogram and cumulative probability plot (inset) from one of the experiments contributing to the data
illustrated at the top recorded either before (gray dashed line/gray symbols) or after (solid line/black symbols) the application of
LY294002, showing that there is no change in the distribution of events in the absence or presence of this inhibitor. C, Bath
application of wortmannin (100 nM; n 6) blocks the induction of DPP, whereas interleaved control experiments (n 6) show
typical potentiation of mEPSC amplitudes. D, Bath application of LY294002 (5M; n 6) blocks the induction of DPP, whereas
interleaved control experiments (n 5) show typical potentiation ofmEPSC amplitudes. E, The inactive analog LY303511 (5M;
n 5) does not prevent the induction of DPP. For experiments illustrated in C–E, drugs were present throughout the duration of
these recordings. Error bars indicate the mean SEM.
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however, we found no evidence that the
calcium currents evoked by the depolariz-
ing pulses were altered in the presence of
wortmannin (data not shown), ruling out
the trivial explanation that the inhibition
of PI3 kinase blocks DPP by reducing cal-
cium entry during the induction of the po-
tentiation. We additionally confirmed the
role of PI3 kinase in DPP by performing a
series of experiments in the presence of
LY294002 (5 M; n 6). Figure 5D shows
that, as was the case with wortmannin,
LY294002 also completely blocked the in-
duction of DPP, whereas interleaved con-
trol experiments (n  5) showed potenti-
ation. Finally, to ensure that the block of
DPP by LY294002was not attributable to a
nonspecific action of this drug because of
its chemical nature, we performed a series
of experiments in the presence of
LY303511 (5 M), an inactive analog of
LY294002. These two compounds differ at
only one position: their morpholine rings,
in which a nitrogen atom in LY303511 re-
places the oxygen found in LY294002. As
shown inFigure5E,DPPwasobtained in the
presence of this inactive analog (n 5).
Reversing the potentiation of mEPSC
amplitudes with PI3 kinase inhibitors
Inhibitors of PI3 kinase applied after the
induction of LTP can reverse the increase
in synaptic efficacy that is observed (Sanna
et al., 2002). However, it also has been re-
ported that the concentrations of inhibi-
tors required to reverse LTP maintenance
also affect nonpotentiated (control) path-
ways (Opazo et al., 2003). We examined
whether it was possible to reverse the DPP
of mEPSCs by using the same concentra-
tions of PI3 kinase inhibitors that we had
demonstrated had no effect on the baseline amplitudes of mEP-
SCs (Fig. 5). Figure 6A illustrates the design of experiments (n
8) to assess the role of PI3 kinase in the maintenance of the
increasedmEPSC amplitudes. After inducingDPP and observing
an increase in mEPSC amplitudes, we exchanged the external
recording solution to one that containedwortmannin (100 nM; as
indicated by the bar). This resulted in a reversal of the potentia-
tion, and within the time course of the experiment the mean
amplitudes of mEPSCs returned to levels that were not signifi-
cantly different from those recorded before the application of
depolarizing pulses ( p 0.8;Mann–WhitneyU). Example traces
of mEPSCs recorded at the various time points indicated are
shown in Figure 6B; the average mEPSC time course recorded at
each of these time points is indicated in Figure 6C. These average
traces also indicate that there was no alteration in the kinetic
parameters of mEPSCs associated with the reversal of DPP. To
confirm this inhibition of the maintenance of DPP, we also ex-
amined the effects of LY294002. As is to be expected if this rever-
sal is attributable to an inhibition of ongoing PI3 kinase activity,
we observed a similar reversal of DPP with LY294002 (n  7)
(Fig. 6D), whereas reversal of the potentiation was not seen when
the inactive analog LY303511 (n 4) was applied (Fig. 6E).
N-ethylmaleimide and botulinum toxin A inhibit DPP
Increases in the amplitude of mEPSCs are attributed most easily
to an increase in the number of receptors activated by a single
packet of transmitter. Although such a change could be ac-
counted for by an increase in the probability that AMPARs open
(Popen) after the binding of glutamate, this can occur only if Popen
is sufficiently low to allow it to be modulated by a factor large
enough to account for the change in mEPSC amplitude. Addi-
tionally, an alteration in the single-channel conductance of syn-
aptically located AMPARs also could account for the increase in
mEPSC amplitudes we have observed. Indeed, both of these types
of modulation have been proposed as mechanisms of AMPAR-
mediated changes in synaptic strength (Benke et al., 1998; Banke
et al., 2000) (for review, see Erreger et al., 2004). An alternative
mechanism also has been described inwhich there is postsynaptic
SNARE-dependent change in synaptic strength that results in the
insertion of AMPARs into spines after activity-dependent or
pharmacologically induced changes in synaptic strength (Lledo et
al., 1998; Nishimune et al., 1998; Song et al., 1998; Shi et al., 1999,
2001; Lu et al., 2001) (for review, see Malinow and Malenka,
2002; Bredt and Nicoll, 2003; Collingridge et al., 2004). It is this
latter mechanism that we investigated to determine whether the
Figure 6. Inhibitors of PI3 kinase can reverse the increase in mEPSC amplitudes induced by DPP. A, Bath application of
wortmannin (100nM;n8) after the inductionofDPP reverses the increase inmEPSCamplitude.Within10minof theapplication
of this PI3 kinase inhibitor, themean amplitudes of mEPSCs return to baseline levels.B, Superimposed sweeps onmEPSC activity
recorded during the control period (1), at approximately the peak of the potentiation (2), and after wortmannin has reversed the
increase caused by the application of depolarizing pulses (3). C, Examples of mean time courses of mEPSCs recorded during the
periods indicated in A and B. The 10–90% rise times for the meanmEPSC from all three time periods are similar (control, 1.5
0.1ms; potentiated, 1.6 0.1ms;wortmannin-treated, 1.2 0.2ms). Similarly, the decay time constants show little difference
among the three groups (control, 10.0 0.7 ms; potentiated, 11.2 0.3 ms; wortmannin-treated, 10.0 1.1 ms). D, The PI3
kinase inhibitor LY294002 (5M; n 7) also reverses the increase in mEPSC amplitudes induced by depolarizing pulses, with a
time course similar to that seen with wortmannin. E, The inactive analog LY303511 (5M; n 4) does not result in a reversal of
DPP. Error bars indicate the mean SEM.
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insertion of AMPARs into synaptic sites could account for the po-
tentiation of mEPSC amplitudes.
We first examined the effect of NEM, a broad spectrum inhib-
itor of N-ethylmaleimide-sensitive fusion protein (NSF), on the
amplitude of mEPSCs.We included NEM (5mM) in the solution
used to fill the patch pipettes to attempt to restrict its actions to
the postsynaptic cell, because bath application of NEM also
would be expected to interfere with SNAREs located in the pre-
synaptic nerve terminal and, hence, transmitter release. In the
absence of depolarizing pulses NEM did not affect the individual
amplitudes of mEPSCs nor their distribution (Fig. 7A,B). The
mean amplitude of events recorded in the presence of NEM was
24.1 0.4 pA and remained stable during the time course of these
experiments (n 3 experiments) (Fig. 7C). In addition,NEMdid
not alter the rise times or decay time constants of mEPSCs when
compared with control events, these values being 1.0  0.3 and
10.2 1.9ms, respectively (data not shown). Each of these sets of
parameters is not significantly different from the equivalent val-
ueswe obtained in the control recordings ofmEPSCs, the data for
which are illustrated in Figure 1 ( p  0.1 for all tests; Mann–
Whitney U). However, we did observe that NEM reduced, signif-
icantly, the frequency of mEPSCs after 25–30 min of whole-cell
recording (from 1.9  0.1 to 1.0  0.1 Hz; p  0.05; Mann–
WhitneyU) (Fig. 7D). This reduction in frequency is greater than
and has a different profile from the “rundown” in mEPSC fre-
quencies that we observed in earlier experiments (Fig. 1D) and
may be taken as evidence that the interaction of AMPARs with
NSF is required for constitutive cycling of these receptors (Lledo
et al., 1998; Noel et al., 1999).
We next examined whether NEM could prevent the increase
in mEPSC amplitudes seen after the application of depolarizing
pulses. Figure 8A shows examples of superimposed traces of
mEPSC activity recorded before and after the application of de-
polarizing pulses in a single experiment and indicates that no
increase in the amplitude of events occurs whenNEM is included
in the internal solution filling the patch pipette. A plot of the
individual amplitudes of events recorded
in a single experiment and histograms of
mEPSCamplitudes and the corresponding
cumulative probability plots (Fig. 8B,C)
also confirm that the presence of NEM pre-
vents the induction of DPP. The mean data
from all experiments (n 6) inwhichNEM
was included in the patch pipette and corre-
sponding interleaved control experiments
(n 6) are illustrated in Figure 8D.
We next examined the effects of an-
other inhibitor ofmembrane fusion events
on DPP. Botulinum toxin A, when acting
at presynaptic nerve terminals, inhibits the
action of synaptosome-associated protein
of 25 kDa (SNAP-25) and also has been
shown to block the potentiation of synap-
tic currents afterNMDAR-dependent LTP
(Lledo et al., 1998). Again, for this series of
experiments we included this toxin in the
solution filling the patch pipette. As a pos-
itive control for this series of experiments,
we confirmed that the stock solution and
concentration used (10 ng/ml) were suffi-
cient to block synaptic transmission at the
mouse neuromuscular junction (data not
shown) (courtesy of R. R. Ribchester and
D. Thomson, University of Edinburgh, UK). The effects of toxin
were similar to those reported forNEM. Thus, as shown in Figure
8E–H, no evidence for an increase inmEPSC amplitude was seen
when botulinum toxin A was included in the patch pipette. The
meandata fromall experiments (n7) inwhichbotulinumtoxinA
was included in the patch pipette and corresponding interleaved
control experiments (n 5) are illustrated in Figure 8H.
Preventing the interaction of glutamate receptor 2 AMPAR
subunits with NSF and protein interacting with C kinase 1
inhibits DPP
The experiments showing that NEM and botulinum toxin A in-
hibit DPP imply a role of SNARE complexes and SNAP-25 in the
induction of this form of plasticity. However, in the experiments
described above, there is the possibility that some of the effects of
NEM and botulinum toxin A may be mediated by these inhibi-
tors diffusing from the postsynaptic neuron to affect the function
of presynaptic release sites, and this may contribute to the inhi-
bition of DPP of mEPSCs. Thus to gain insight into the mecha-
nism by which an increase in mEPSC might be achieved, we
performed additional experiments with a series of short-
sequence peptides that inhibit the interaction of AMPAR sub-
units with proteins involved in the trafficking of these subunits to
the cell surface.
Pep2m is a 10-amino-acid sequence that targets theNSF bind-
ing motif on the glutamate receptor 2 (GluR2) AMPAR subunit.
This peptide has been reported to reduce the amplitude of evoked
EPSCs and decrease the surface expression of AMPAR subunits
when it is included in internal recording solutions (Nishimune et
al., 1998; Lu¨scher et al., 1999; Luthi et al., 1999; Noel et al., 1999;
Kim and Lisman, 2001; Shi et al., 2001; Gardner et al., 2005; Liu
and Cull-Candy, 2005). This reduction in evoked EPSC ampli-
tudes may arise from the fact that, during recording, the same
populations of synapses are sampled over a prolonged period.
Thus, if GluR2 receptor subunits are trafficked (constitutively
cycled) on a relatively short time scale (but see Adesnik et al.,
Figure7. NEMdoes not affect the amplitude ofmEPSCs but reduces their frequency.A, Data froma single experiment showing
the amplitude of individual mEPSCs recorded with a patch pipette filled with an internal solution containing NEM (5 mM). B,
Amplitude histogram and cumulative probability plot (inset) of the data shown in A. C, Pooled data (n 3) showing that the
amplitudes ofmEPSCs are stable in the presence of NEMover a 30min recording period.D, NEM causes the frequencies ofmEPSCs
to decrease during the course of a 30min recording. The dashed line indicates the normalizedmEPSC frequency observed during
the initial 5 min of recording. Error bars indicate the mean SEM.
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2005), then a reduction in their amplitude
will be observed because their insertion
will be blocked. However, when mEPSCs
are monitored, it is unlikely that mEPSCs
arising from the same synaptic site will be
recorded on multiple occasions. There-
fore, in the case of mEPSCs a reduction in
their amplitude may not be detected, al-
though a reduction in frequency may oc-
cur if clusters of AMPARs are trafficked
into and out of spines. Nonetheless, we
testedwhether pep2m (50M) affected the
amplitude of mEPSCs recording in the ab-
sence of depolarizing pulses (Fig. 9A). The
mean amplitude of mEPSCs recorded in
these experiments (n  4) was 29.5  3.3
pA, which although higher than some of
the amplitudes recorded in our control ex-
periments, does not indicate that pep2m
causes a generalized decrease in mEPSC
amplitudes similar to that reported for
evoked EPSCs (Noel et al., 1999). We did
observe that the frequency of mEPSCs was
reduced significantly ( p  0.05; Mann–
Whitney U) during the time course of
these experiments (Fig. 9B) from an initial
value of 1.3 0.2 to 0.9 0.1 Hz after 25
min of whole-cell recording. However,
this reduction in frequency is not signifi-
cantly different from our control record-
ings ( p  0.05; Mann–Whitney U) (Fig.
1D); thus it is difficult to ascribe, unequiv-
ocally, this reduction to a specific action of
pep2m as has been suggested previously
(Noel et al., 1999) (but see Liu and Cull-
Candy, 2005). Nonetheless, consistent
with the idea that the infusion of pep2m
affects the properties of, or results in an
ablation of,mEPSCs originating from syn-
apses proximal to the soma, we observed
an increase in both the rise time and decay
time constants of mEPSCs recorded to-
ward the end of the 30 min recording pe-
riod, compared with events recorded un-
der control conditions. These values were
1.7 0.1 and 21.1 0.9 ms, respectively,
which is to be expected if such events orig-
inated from more distal sites (Noel et al.,
1999).
Figure 10A illustrates the effects of
pep2m (50 M) on DPP. Superimposed
sweeps onmEPSC activity recorded before
and after the application of depolarizing
pulses indicate that there is little change in
the amplitude of these events in the pres-
ence of this inhibitor. Comparison of am-
plitude histograms and corresponding cumulative probability
plots confirmed that the induction of DPP is blocked by pep2m.
To ensure that the action of pep2m was not attributable to a
nonspecific effect of including this peptide in the internal record-
ing solution, we also performed experiments with pep4c, a 10-
amino-acid peptide that differs from pep2m in position 8, where
the asparagine residue of pep2m is replaced by a serine residue.
This single amino acid substitution prevents pep4c from inter-
acting with the NSF binding domain of the GluR2 AMPAR sub-
unit (Nishimune et al., 1998). In a series of experiments (n 3;
data not shown) we confirmed that pep4c did not affect the am-
plitude of mEPSCs in the absence of depolarizing pulses (23.1
2.0 pA). In these experiments we also noted that pep4c did not
affect the frequency of mEPSCs nor their rise time or decay time
Figure 8. NEM or botulinum toxin A applied to the postsynaptic cell blocks the induction of DPP. A, Superimposed sweeps of
mEPSCactivity recordedbefore (top traces) andafter (bottom traces) the applicationof depolarizingpulses in thepresenceofNEM
(5mM).B, Plot of the individual amplitudes ofmEPSCs recorded in an example experiment. Depolarizing pulseswere applied after
5min; it is apparent that after the depolarizing pulses therewas no clear increase in the amplitudes of the largest events recorded
nor a shift in the amplitude of the smallest events seen in experiments in which NEM was absent (Fig. 2B, for example). C,
Amplitude histogram and cumulative probability plot (inset) of the data illustrated in B recorded in the control period (gray
dashed line/gray symbols) and in a similar time period after the application of depolarizing pulses (solid line/black symbols). Both
the histogram and cumulative probability plot of mEPSC amplitudes are similar and indicate that the presence of NEM in the
internal recording solutionblocked thepotentiation.D,Meandata fromall experiments inwhichNEMwas included in the internal
recording solution (n 6) and data from interleaved control experiments (n 6). DPP was blocked in all of the cells that were
examined when NEM was present, whereas typical potentiation was seen in the interleaved control experiments; error bars
indicate the mean SEM. E, Superimposed sweeps of mEPSC activity recorded before (top traces) and after (bottom traces) the
application of depolarizing pulses in the presence of botulinum toxin A (10 ng/ml). F, Plot of the individual amplitudes ofmEPSCs
recorded in an example experiment. Depolarizing pulses were applied after 5 min, and, similar to the data obtained with NEM,
botulinum toxin A prevented the increase in the amplitudes of the largest events recorded and a shift in the amplitude of the
smallest events.G, Amplitude histogramand cumulative probability plot (inset) of the data illustrated in F recorded in the control
period (gray dashed line/gray symbols) and in a similar time period after the application of depolarizing pulses (solid line/black
symbols). No significant differenceswere seen in these distributions.H, Mean data fromall experiments inwhich botulinum toxin
A was included in the internal recording solution (n 7) and data from interleaved control experiments (n 5); error bars
indicate themean SEM. DPPwas blocked in all of the cells that were examinedwhen botulinum toxin Awas present, whereas
potentiation was seen in the interleaved control experiments.
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constants (1.2  0.3 Hz; 1.2  0.2 and 14.0  1.0 ms, respec-
tively). In the presence of pep4c (50 M) we observed typical
potentiation of mEPSCs after the application of depolarizing
pulses (Fig. 10B). Increases in the amplitude of the largest
mEPSCs recorded, together with an increase in the amplitude of
the smallest events, are clearly visible. As is to be expected, am-
plitude histograms and cumulative probability plots of mEPSCs
recorded after the application of depolarizing pulses in the pres-
ence of pep4c were significantly different ( p 0.01; Kolmogor-
ov–Smirnov) (Fig. 10B, bottom panel). The mean potentiation
seen in all experiments performed in the presence of either
pep2m(n 8) or pep4c (n 4) is shown in Figure 10C. Although
typical potentiation is seen in the presence of pep4c, cells treated
with pep2m show no potentiation other than a modest, transient
increase in mEPSC amplitudes in the first few minutes after the
induction protocol.
In addition to the interaction of GluR2 subunits with the NSF
protein, synaptic expression and composition of AMPARs have
been shown to be dependent on the action of protein interacting
with C kinase 1 (PICK1) (Li et al., 1999; Chung et al., 2000; Daw
et al., 2000; Perez et al., 2001; Hirbec et al., 2002; Terashima et al.,
2004). The 11-amino-acid peptide pep2-AVKI is directed against
the PICK1/GluR2 receptor-binding motif (Osten et al., 2000)
without affecting interactions with other proteins, such as GRIP/
ABP (glutamate receptor-interacting protein/AMPAR-binding
protein), which also are involved in the trafficking of AMPARs
containing this subunit. We investigated whether this peptide
could prevent DPP. In a series of control experiments (n 3)
we confirmed, in agreement with a recent report (Liu and
Cull-Candy, 2005), that this peptide did not affect mEPSC
amplitudes (20.0  3.6 pA) or frequencies (1.6  0.2 Hz) in
the absence of depolarizing pulses (Fig. 9C,D). The values are
not significantly different from those illustrated in Figure 1D
( p  0.05; Mann–Whitney U). However, as shown in the
pooled data (n  8) illustrated in Figure 10D, pep2-AVKI
prevented the increase in mEPSC ampli-
tudes after the application of depolarizing
pulses. As with pep2m, we observed a small
transient potentiation of amplitudes imme-
diately after the induction protocol.
GluR1 subunit interactions with
synapse-associated protein-97 are
required for DPP
AMPARs in CA1 pyramidal neurons con-
tain GluR2 subunits existing predomi-
nately as heteromeric complexes of
GluR1/GluR2 receptor subunits orGluR2/
GluR3 receptor subunits (Wenthold et al.,
1996) (for review, see Bredt and Nicoll,
2003). The experiments described above
have examined only the interaction of the
GluR2 receptor subunit with membrane
fusion/trafficking processes. Although
GluR2 subunit interactions with NSF and
PICK1 have been suggested to play an im-
portant role in constitutive cycling of AM-
PARs, the mechanisms of expression of
LTP may involve, in addition, interaction
of the GluR1 subunit with calcium/
calmodulin-dependent protein kinase II
(CaMKII) and synapse-associated
protein-97 (SAP-97) (Leonard et al., 1998;
Hayashi et al., 2000; Shi et al., 2001; Rumbaugh et al., 2003). The
11-amino-acid peptide pep1-TGL is a peptide sequence targeted
to the TGL motif found in the C terminus of the GluR1 subunit
that binds to SAP-97 (Hayashi et al., 2000; Shi et al., 2001). We
investigated, by interfering with this interaction between GluR1
and SAP-97, whether DPP was compromised.
As with all of the peptides investigated in this study, we
examined, initially, the effect of pep1-TGL (50 M) on mEP-
SCs recorded from CA1 pyramidal neurons in the absence of
any depolarizing pulse-stimulating protocol. The mean am-
plitude of mEPSCs recorded in the presence of pep1-TGL
(23.1 3.1 pA; n 3) (Fig. 9E) was not significantly different
from mean values recorded in control cells ( p 0.05; Mann–
Whitney U). Additionally, pep1-TGL did not alter the mEPSC
frequencies (Fig. 9F ) nor their kinetic properties. However,
inclusion of pep1-TGL (50 M) in the internal recording so-
lution resulted in a block of the potentiation of mEPSC am-
plitudes induced by depolarizing pulses. The mean data ob-
tained from all experiments performed in the presence of
pep1-TGL (n  7) and the corresponding interleaved control
experiments (n  5) are shown in Figure 10E.
Discussion
DPP: comparison with NMDAR-dependent LTP
Changes in synaptic strength in the CA1 region of the mamma-
lian hippocampus, whether these result in increased or decreased
activity, are triggered initially by spatiotemporal changes in intra-
cellular calcium levels. Conventional NMDAR-dependent LTP-
inducing protocols result in only a small percentage of synapses ex-
periencing this change incalciumlevel,makingchanges inminiature
synaptic events difficult to observe (but see Manabe et al., 1992).
Although the potentiation described in this paper is not dependent
on NMDAR activation and is unlikely to be equivalent to CA1
NMDAR-dependent LTP, our results show that increases in synap-
tic activity brought about by activation of VDCCs share common
Figure 9. Effects of peptide inhibitors on control mEPSC amplitudes and frequencies. A,B, Effect of pep2m (50M; n 4) on
mEPSCs recorded in theabsenceof depolarizingpulses. Althoughpep2mdoesnot affect theamplitudeof events, their frequencies
are reduced significantly in the final 10 min of the recording period as compared with the initial 10 min of recording ( p 0.05;
Mann–Whitney U). C,D, Pep2-AVKI (50M; n 3) does not affect the amplitude of mEPSCs. The frequencies of mEPSCs are not
significantly different during the initial and final 10min of recording ( p 0.05, Mann–Whitney U). E, F, Pep1-TGL (50M; n
3)on its owndoesnot affect theamplitudesor frequencies ofmEPSCs. Thedashed lines indicate thenormalizedmEPSCamplitudes
or frequencies observed during the initial 5 min of recording. Error bars indicate the mean SEM.
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signaling pathways and expression mecha-
nisms, with changes in synaptic efficacy re-
sulting fromNMDAR-dependent LTP.
The role of VDCCs in NMDAR-
dependent LTP induced by theta burst stim-
ulation has been investigated (Grover and
Teyler, 1990;Morgan andTeyler, 2001), and
these studies have provided evidence that, in
addition to anNMDAR-dependent compo-
nent to theta burst-induced LTP, VDCCs
can be activated and induce potentiation of
synaptic potentials that areblockedbynifed-
ipine. Thus, although DPP is not equivalent
to such theta burst-induced potentiation
(because it shows no NMDAR-dependent
component), there is reason to believe that
our induction protocol activates signaling
cascades that also canbe triggeredwithphys-
iologically relevant stimuli.
Our finding that the potentiation was
stable over the time course of our experi-
ments, rather than transient, is in contrast
to earlier reports (Kullmann et al., 1992;
Wyllie and Nicoll, 1994; Wyllie et al.,
1994). Earlier studies were performed by
using acute slices andwere performed on a
different species (guinea pig compared to
rat). Nevertheless, using rat acute slices,
Hendricson and colleagues (2003) have re-
ported transient potentiation with the use
of a protocol similar to that describe here.
One intriguing possibility to explain the
temporal differences in the potentiation is
that levels of phosphatase activity are dif-
ferent in acute and organotypic slices. In
experiments that used acute slices, Wyllie
and Nicoll (1994) showed that inhibition
of phosphatase activity converted tran-
sient potentiation to a stable form. Alter-
natively, organotypic slice preparations
simply might give rise to a potentiation
that decays more slowly and that was not
detected during the time course of our ex-
periments. Our fundamental observa-
tions, namely that DPP of mEPSC ampli-
tudes is NMDAR-independent, requires
activation of L-type VDCCs, and is
blocked by postsynaptic chelation of cal-
cium, are similar to those reported in the
original study (Wyllie et al., 1994). In ad-
dition, the experiments with ryanodine
and thapsigargin reveal a requirement for
functional intracellular calcium stores in
the induction of DPP. It remains to be de-
termined whether calcium itself triggers
intracellular release or whether it results from second messenger
action, e.g., inositol triphosphate-stimulated release.
It should be noted that, although our data demonstrate that
DPP and NMDAR-dependent LTP show some similarities in
terms of expression mechanisms, calcium entry via VDCCs does
not substitute for calcium entry via NMDARs in other processes
triggered by NMDAR activation. For example, excitotoxicity ini-
tiated by calcium entry via NMDARs is notmimicked by calcium
entry via VDCCs even when levels of calcium entry through VD-
CCs are equal to, or greater than, those sufficient to trigger cell
death via NMDARs (Tymianski et al., 1993; Sattler et al., 1998;
Hardingham and Bading, 2003).
PI3 kinase and DPP
PI3 kinase plays a pivotal role in intracellular signaling cascades
and is a common target (or link) with other biochemical trans-
Figure10. Pep2m, pep2-AVKI, and pep1-TGL each block the induction of DPP.A, Top, Superimposed sweeps ofmEPSC activity
recorded before (top traces) and after (bottom traces) the application of depolarizing pulses in the presence of pep2m (50M).A,
Bottom, Amplitude histogram and cumulative probability plot (inset) of mEPSC amplitudes recorded in a control period (gray
dashed line/gray symbols) and in a similar time period after the application of depolarizing pulses (solid line/black symbols). No
significant differences are seen in these distributions.B, Top, Shown are superimposed sweeps ofmEPSC activity recorded before
(top traces) andafter (bottomtraces) theapplicationofdepolarizingpulses in thepresenceofpep4c (50M), apeptide thatdiffers
from pep2m by a single amino acid; the asparagine residue at position 8 of pep2m is replaced by a serine residue in pep4c. In the
presence of pep4c, clear potentiation of mEPSC amplitudes can be seen. B, Bottom, Amplitude histogram and cumulative prob-
ability plot (inset) of mEPSC amplitudes recorded in a control period (gray dashed line/gray symbols) and in a similar time period
after the application of depolarizing pulses (solid line/black symbols). Shifts in mEPSC amplitudes are clearly apparent in both
distributions, indicating thatpep4cdoesnotprevent the inductionof thepotentiation.C,Meandata fromall experiments inwhich
either pep2m (f; n 8) or pep4c (F; n 4) was included in the internal recording solution; error bars indicate the mean
SEM. Only in the presence of pep2m is DPP blocked. D, Mean data from all experiments in which pep2-AVKI (f; n 8) was
included in the internal recording solution and corresponding control experiments performedduring the sameperiod (F;n 3);
error bars indicate the mean  SEM. A small but transient potentiation of mEPSC amplitudes was seen in the presence of
pep2-AVKI.E,Meandata fromall experiments inwhichpep1-TGL (f;n7)was included in the internal recording solution; error
bars indicate the mean SEM. Complete block of potentiation was observed when this peptide was present. Data from inter-
leaved control experiments (F; n 5) showed typical potentiation.
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ductionmechanisms thought to be involved in LTP (for example,
NMDAR-dependent ERK activation). Our findings that DPP
also has a dependency on PI3 kinase suggest that the processes
activated by calcium entry either through NMDARs or VDCCs
may have a common convergence; whether this is at the level of
the kinase itself or upstream or downstream of PI3 kinase re-
mains to be determined. We did not examine the mechanism by
which calcium entry via VDCCs results in PI3 kinase activation.
Because DPP also has a requirement for CaMKII activity (Wyllie
and Nicoll, 1994), activation of PI3 kinase may depend on up-
stream signaling cascades rather than on direct activation of PI3
kinase by calcium entry from VDCCs. In this respect it is inter-
esting to note that Sanna and colleagues (2002) also report that a
VDCC-dependent form of LTP is blocked by LY294002. Further-
more, our data lend support to the argument that inhibiting the
activity of PI3 kinase can reverse the increase in synaptic strength
after LTP (Sanna et al., 2002) (but seeOpazo et al., 2003). The fact
that neither of the PI3 kinase inhibitors used in this study affected
the mean mEPSC amplitudes in control recordings suggests that
this kinase does not play a prominent role in maintaining surface
expression of AMPARs (at least on the time scale monitored in
this study). Rather, PI3 kinase activity is essential in the induction
and maintenance of the potentiation. We did not, in the experi-
ments addressing reversibility of potentiation, examine themain-
tenance phase sensitivity to PI3 kinase inhibitors by applying
these to slices at later time intervals. In this respect it is interesting
to note that, following NMDAR-dependent LTP, AMPARs com-
posed of GluR1/GluR2 subunits are inserted rapidly into mem-
branes, only to be replaced at a later time with complexes con-
tainingGluR2/GluR3 (Shi et al., 2001; Lee et al., 2004), indicating
that mechanisms exists for the replacement of recently inserted
AMPA receptors. Thus the sensitivity of reversibility of DPP to
PI3 kinase inhibitors may be related to this mechanism. In addi-
tion to our present results showing a role for PI3 kinase inDPP, it
is interesting to note that protein kinase A (PKA) also has been
implicated in AMPAR subunit trafficking in synaptic plasticity-
induced organotypic slice cultures (Esteban et al., 2003). It re-
mains to be determined whether there is any PKA dependency of
DPP.
Membrane fusion events, receptor trafficking, and DPP
Inhibitors of membrane fusion events, together with small pep-
tides that disrupt the interaction of AMPAR subunits with pro-
teins involved in receptor trafficking, each blocked the induction
of DPP. Although both NSF and botulinum toxin A have been
shown to block the induction of NMDAR-dependent LTP (Lledo
et al., 1998), experiments that used the inhibitory peptide pep2m
to block the interaction of the GluR2 AMPAR subunit with NSF
generally have concluded that the GluR2–NSF interaction is in-
volved in the constitutive cycling of AMPARs (Nishimune et al.,
1998; Lu¨scher et al., 1999; Luthi et al., 1999; Noel et al., 1999; Kim
and Lisman, 2001; Shi et al., 2001; Gardner et al., 2005; Liu and
Cull-Candy, 2005) and in the expression of long-term depression
(LTD) (Lu¨scher et al., 1999; Luthi et al., 1999). In this respect the
effects of pep2m on DPP contrast with those seen with conven-
tional LTP.
Conflicting reports exist concerning the role of PICK1 in reg-
ulating AMPARs at synapses. In the hippocampus PICK1 de-
creases GluR2 subunit expression by promoting internalization
of AMPARs (Kim et al., 2001; Perez et al., 2001) and thus may be
involved in the expression of LTD but also can increase the inser-
tion of AMPARs by releasing them from intracellularmembranes
(Daw et al., 2000) or by promoting the expression of GluR2 lack-
ing AMPARs (Terashima et al., 2004). In the cerebellum PICK1
promotes the insertion ofGluR2-containingAMPARs after high-
frequency stimulation of synaptic inputs to stellate cells (Gardner
et al., 2005; Liu and Cull-Candy, 2005). We observed that the
inhibitory peptide pep2-AVKI, which blocks the interaction of
the GluR2 subunit with PICK1, blocks the DPP of mEPSC am-
plitudes. However, we have not investigated the rectification
properties of potentiated mEPSCs and therefore cannot deter-
mine whether this stimulation protocol results in a similar
change that has been seen with high-frequency stimulation of
inputs to stellate cells.We did, however, observe a small transient
potentiation in the presence of pep2-AVKI, whichmight indicate
that other trafficking proteins can mediate, albeit to a lesser ex-
tent, aspects of this potentiation.
In our final set of experiments we observed that blocking the
interaction of GluR1 subunits with SAP-97 with the peptide
pep1-TGL also inhibited DPP. This suggests that, in addition to
interactions of GluR2with trafficking proteins, there is a require-
ment for an intact GluR1 trafficking mechanism to allow DPP to
be established.Whether the nature of the stimulus used to induce
DPP reveals a different mechanism for receptor trafficking than
has been suggested for NMDAR-dependent LTP or whether such
interaction also can occur in other forms of activity-dependent
changes in synaptic strength remains to be determined.
Conclusion
Our data support the emerging consensus that rises in intracel-
lular calcium lead to increases in synaptic efficacy by increasing
the number of functional AMPARs expressed in spines. The in-
crease in mEPSC amplitudes triggered by depolarizing pulses is
mediated by a signaling cascade that involves PI3 kinase and the
interaction of AMPAR subunits with proteins such as NSF,
PICK1, and SAP-97 and, in this respect, shares a commonality
with NMDAR-dependent plasticity. The ability to induce
changes at a large number of sites throughout the dendritic
tree of a CA1 pyramidal cell provides a mechanism to investi-
gate alterations in synaptic strength by using biochemical and
imaging techniques that have, to date, been reliant mainly on
pharmacologically induced potentiation to achieve cell-wide
potentiation.
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